인쇄하기
취소

Korean drugmakers at a crossroads

Published: 2013-08-13 06:56:00
Updated: 2013-08-13 06:56:00
Many experts say that the country's medicine business is standing at a crossroads. Is it going take a leap with new, innovative drugs or continue chasing global leaders with generic products?

The Korea Pharmaceutical Manufacturers Association (KPMA) says generic drugs take up 40 percent of the market in terms of revenue. Moreover, investment to create new drugs remains minimal, as a combined...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.